FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 150 filers reported holding FATE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,427 | +14.6% | 673,290 | +157.4% | 0.01% | +16.7% |
| Q2 2023 | $1,245 | +225.9% | 261,611 | +590.0% | 0.01% | +140.0% |
| Q4 2022 | $382 | -100.0% | 37,915 | -64.3% | 0.01% | -80.8% |
| Q3 2022 | $2,378,000 | -29.5% | 106,125 | +86.6% | 0.03% | +23.8% |
| Q3 2021 | $3,371,000 | -65.9% | 56,876 | -50.1% | 0.02% | -76.9% |
| Q2 2021 | $9,889,000 | +570.0% | 113,943 | +601.6% | 0.09% | +203.3% |
| Q4 2020 | $1,476,000 | +232.4% | 16,241 | -43.2% | 0.03% | +42.9% |
| Q3 2019 | $444,000 | -23.8% | 28,603 | -20.2% | 0.02% | -76.9% |
| Q3 2018 | $583,000 | – | 35,845 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |